Economic impact of screening for bladder cancer using bladder tumor markers: A decision analysis
Authors:
- Arthur I. SagalowskyASArthur I. Sagalowsky
- Yair LotanYLYair Lotan
- 1 July 2006
- journal article
- review article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 24 (4) , 338-343
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Detection of Bladder Cancer Using a Point-of-Care Proteomic AssayJAMA, 2005
- Cost-effectiveness of Whole-Body CT ScreeningRadiology, 2005
- Screening for Cancer: Are Resources Being Used Wisely?2005
- Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analysesUrology, 2003
- SCREENING AND MONITORING FOR BLADDER CANCER: REFINING THE USE OF NMP22Journal of Urology, 2001
- Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancerUrology, 1998
- Utilization of Nuclear Matrix Proteins for Cancer DiagnosisCritical Reviews™ in Eukaryotic Gene Expression, 1996
- An economic rationale forprostate cancer screeningUrology, 1994
- A Community Study of Bladder Cancer Screening by the Detection of Occult Urinary BleedingJournal of Urology, 1992
- Hematuria Screening for Bladder CancerJournal of Occupational and Environmental Medicine, 1990